These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36595209)

  • 21. A child with a deletion in the monocarboxylate transporter 8 gene: 7-year follow-up and effects of thyroid hormone treatment.
    Zung A; Visser TJ; Uitterlinden AG; Rivadeneira F; Friesema EC
    Eur J Endocrinol; 2011 Nov; 165(5):823-30. PubMed ID: 21896621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis.
    Mayerl S; Müller J; Bauer R; Richert S; Kassmann CM; Darras VM; Buder K; Boelen A; Visser TJ; Heuer H
    J Clin Invest; 2014 May; 124(5):1987-99. PubMed ID: 24691440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations.
    Anık A; Kersseboom S; Demir K; Catlı G; Yiş U; Böber E; van Mullem A; van Herebeek RE; Hız S; Abacı A; Visser TJ
    Horm Res Paediatr; 2014; 82(4):261-71. PubMed ID: 25247785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired T3 uptake and action in MCT8-deficient cerebral organoids underlie Allan-Herndon-Dudley syndrome.
    Salas-Lucia F; Escamilla S; Bianco AC; Dumitrescu A; Refetoff S
    JCI Insight; 2024 Feb; 9(7):. PubMed ID: 38376950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction.
    Chan SY; Franklyn JA; Pemberton HN; Bulmer JN; Visser TJ; McCabe CJ; Kilby MD
    J Endocrinol; 2006 Jun; 189(3):465-71. PubMed ID: 16731778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression.
    Frints SG; Lenzner S; Bauters M; Jensen LR; Van Esch H; des Portes V; Moog U; Macville MV; van Roozendaal K; Schrander-Stumpel CT; Tzschach A; Marynen P; Fryns JP; Hamel B; van Bokhoven H; Chelly J; Beldjord C; Turner G; Gecz J; Moraine C; Raynaud M; Ropers HH; Froyen G; Kuss AW
    Eur J Hum Genet; 2008 Sep; 16(9):1029-37. PubMed ID: 18398436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of iPSC lines with SLC16A2:G401R or SLC16A2 knock out.
    Ludwik KA; Opitz R; Jyrch S; Megges M; Weiner J; Beule D; Kühnen P; Stachelscheid H
    Stem Cell Res; 2023 Dec; 73():103256. PubMed ID: 38006677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and endocrine features of two Allan-Herndon-Dudley syndrome patients with monocarboxylate transporter 8 mutations.
    Kim JH; Kim YM; Yum MS; Choi JH; Lee BH; Kim GH; Yoo HW
    Horm Res Paediatr; 2015; 83(4):288-92. PubMed ID: 25896225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy in women heterozygous for MCT8 mutations: risk of maternal hypothyroxinemia and fetal care.
    Ramos HE; Morandini M; Carré A; Tron E; Floch C; Mandelbrot L; Neri N; De Sarcus B; Simon A; Bonnefont JP; Amiel J; Desguerre I; Valayannopoulos V; Castanet M; Polak M
    Eur J Endocrinol; 2011 Feb; 164(2):309-14. PubMed ID: 21098685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral cortex hyperthyroidism of newborn mct8-deficient mice transiently suppressed by lat2 inactivation.
    Núñez B; Martínez de Mena R; Obregon MJ; Font-Llitjós M; Nunes V; Palacín M; Dumitrescu AM; Morte B; Bernal J
    PLoS One; 2014; 9(5):e96915. PubMed ID: 24819605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histidines in potential substrate recognition sites affect thyroid hormone transport by monocarboxylate transporter 8 (MCT8).
    Braun D; Lelios I; Krause G; Schweizer U
    Endocrinology; 2013 Jul; 154(7):2553-61. PubMed ID: 23592749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome.
    Wirth EK; Roth S; Blechschmidt C; Hölter SM; Becker L; Racz I; Zimmer A; Klopstock T; Gailus-Durner V; Fuchs H; Wurst W; Naumann T; Bräuer A; de Angelis MH; Köhrle J; Grüters A; Schweizer U
    J Neurosci; 2009 Jul; 29(30):9439-49. PubMed ID: 19641107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development.
    van Geest FS; Gunhanlar N; Groeneweg S; Visser WE
    Front Endocrinol (Lausanne); 2021; 12():723750. PubMed ID: 34539576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Few Amino Acid Exchanges Expand the Substrate Spectrum of Monocarboxylate Transporter 10.
    Johannes J; Braun D; Kinne A; Rathmann D; Köhrle J; Schweizer U
    Mol Endocrinol; 2016 Jul; 30(7):796-808. PubMed ID: 27244477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allan-Herndon-Dudley syndrome (AHDS) caused by a novel SLC16A2 gene mutation showing severe neurologic features and unexpectedly low TRH-stimulated serum TSH.
    Boccone L; Mariotti S; Dessì V; Pruna D; Meloni A; Loudianos G
    Eur J Med Genet; 2010; 53(6):392-5. PubMed ID: 20713192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatiotemporal Changes of Cerebral Monocarboxylate Transporter 8 Expression.
    Wilpert NM; Krueger M; Opitz R; Sebinger D; Paisdzior S; Mages B; Schulz A; Spranger J; Wirth EK; Stachelscheid H; Mergenthaler P; Vajkoczy P; Krude H; Kühnen P; Bechmann I; Biebermann H
    Thyroid; 2020 Sep; 30(9):1366-1383. PubMed ID: 32143555
    [No Abstract]   [Full Text] [Related]  

  • 37. Knockdown of monocarboxylate transporter 8 (mct8) disturbs brain development and locomotion in zebrafish.
    de Vrieze E; van de Wiel SM; Zethof J; Flik G; Klaren PH; Arjona FJ
    Endocrinology; 2014 Jun; 155(6):2320-30. PubMed ID: 24693966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient Activation of Pathogenic ΔPhe501 Mutation in Monocarboxylate Transporter 8 by Chemical and Pharmacological Chaperones.
    Braun D; Schweizer U
    Endocrinology; 2015 Dec; 156(12):4720-30. PubMed ID: 26368820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Early Intervention with Triiodothyroacetic Acid on Peripheral and Neurodevelopmental Findings in a Boy with MCT8 Deficiency.
    Ünsal Y; Hayran G
    J Clin Res Pediatr Endocrinol; 2024 Mar; 16(1):116-122. PubMed ID: 38054413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination.
    Lee JY; Kim MJ; Deliyanti D; Azari MF; Rossello F; Costin A; Ramm G; Stanley EG; Elefanty AG; Wilkinson-Berka JL; Petratos S
    EBioMedicine; 2017 Nov; 25():122-135. PubMed ID: 29111262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.